LNTH:NASDAQ, Lantheus Holdings, Inc.
LNTH stock overview
Lantheus Holdings, Inc. (LNTH:NASDAQ) closed at $100.15 on October 27, 2026,
up 0.23% on the day.
The stock trades 10.5% below its 52-week high of $111.86
and 99.7% above its 52-week low of $50.16.
Over the past year, it gained 74.7%.
Lantheus Holdings, Inc. is part of the Health Care sector (Biotechnology: In Vitro & In Vivo Diagnostic Substances).
Key figures
- Price
- $100.15
- Day change
- +0.23%
- Volume
- 761,404
- Average volume
- 1,402,582
- Market cap
- 6B+
- 52-week range
- $50.16 – $111.86
- 50-day average
- $100.28
- 200-day average
- $90.71
Price action over the past year
In 252 trading sessions since October 27, 2025, LNTH closed higher on 126 days (50%).
Its best day was March 9, 2026 (+10.27%) and its worst was July 6, 2026 (-6.43%).
The stock moved 10% or more in a single session 1 time.
It opened at least 5% above the previous day's high 1 time.
Recent signals
LNTH news
-
Oct 20, 2026:
GE HealthCare Wins Approval for MINItrace Magni Cyclotron in Europe
-
Oct 12, 2026:
1 Russell 2000 Stock with Exciting Potential and 2 That Underwhelm
-
Oct 6, 2026:
1 Healthcare Stock with Exciting Potential and 2 We Find Risky
-
Sep 30, 2026:
Lantheus Announces CMS Grants Transitional Pass-Through Status for PYLARIFY TruVu (piflufolastat F 18)
-
Sep 30, 2026:
Lantheus Announces CMS Grants Transitional Pass-Through Status for PYLARIFY® TruVu (piflufolastat F 18)
-
Sep 29, 2026:
Are BZH, LNTH, BGMS Obtaining Fair Deals for their Shareholders?
-
Sep 28, 2026:
Lantheus Announces First Patient Dosed in SPARROW Phase 2/3 Registrational Trial in Prostate Cancer
-
Sep 26, 2026:
Lantheus Holdings (LNTH) Could Be 7% Undervalued On BRAVNETSA Approval
About Lantheus Holdings, Inc.
Lantheus Holdings Inc develops diagnostic products for the healthcare sector. Its chief product is imaging agents used by physicians in diagnostic procedures such as cardiac ultrasounds and X-ray imaging.
Similar stocks
Find more stocks like LNTH with the
Spikes,
Gaps,
Breakouts and
Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.